Abnormal Basal Ganglia Morphology C4520981
Structural changes in the basal ganglia, brain regions that help control movement. Can lead to movement disorders and neurological symptoms. Management involves treating underlying causes and symptom relief.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Swallowing Difficulty
Problems with swallowing (dysphagia) that can cause choking or aspiration of food or liquids.
Seek immediate medical attention if you experience choking, coughing while eating, or frequent lung infections.
Resting Tremor
(neurologic)Involuntary shaking that occurs when muscles are relaxed, typically affecting the hands, fingers, or limbs.
Frequency: 60-80% of patients
Bradykinesia
(neurologic)Slowness of movement and difficulty initiating voluntary movements, making everyday tasks challenging.
Frequency: 70-85% of patients
Muscle Rigidity
(neurologic)Stiffness and resistance in muscles, making it difficult to move joints through their full range.
Frequency: 60-75% of patients
Involuntary Movements
(neurologic)Abnormal, jerky, or dance-like movements that occur involuntarily, often affecting the face, limbs, or torso.
Frequency: 40-60% of patients
Gait Disturbance
(neurologic)Unsteady walking pattern, shuffling steps, or difficulty maintaining balance while walking.
Frequency: 50-70% of patients
Speech Difficulties
(neurologic)Soft, slurred, or monotone speech, along with difficulty finding words or expressing thoughts.
Frequency: 40-55% of patients
Fatigue
(constitutional)Persistent tiredness and low energy levels that interfere with daily activities.
Frequency: 45-65% of patients
Cognitive Impairment
(neurologic)Problems with memory, attention, executive function, or difficulty processing information.
Frequency: 20-35% of patients
Dystonia
(neurologic)Involuntary muscle contractions causing repetitive movements or abnormal postures.
Frequency: 15-30% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Movement disorder rehabilitation
Specialized PT focusing on balance, gait training, and coordination exercises to address motor dysfunction associated with basal ganglia pathology.
Neurotransmitter-modifying agents
Dopaminergic or other neurotransmitter-targeting medications to address movement symptoms. Selection depends on specific symptom profile and etiology.
Additional treatment options
Neuropsychological intervention
Cognitive-behavioral strategies and compensatory techniques for psychiatric manifestations including depression, anxiety, or cognitive decline.
psychologicalDeep brain stimulation
Neuromodulation surgery for eligible patients with severe, medication-refractory motor symptoms. Requires careful candidate selection and ongoing programming.
surgicalEnvironmental safety adaptations
Home modification, assistive devices, and fall prevention strategies to maintain safety and independence with progressive motor symptoms.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Basal Ganglia Morphology C4520981?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
American Academy of Neurology. Practice parameter: diagnostic assessment of the child with cerebral palsy. Neurology. 2004.
Grab D, Gibbon J, Lanska DJ. Basal Ganglia and Thalamic Lesions. Medscape Reference. 2023.
Kumar R, Syal R. Imaging in Movement Disorders. In: RS Sharma, eds. Clinical Neuroimaging. Jaypee Brothers Medical Publishers. 2018.
Damiano DL, Vaeth MJ, Abel MF. Basal Ganglia Damage and Movement Disorders. In: Brust JCM, ed. Current Diagnosis & Treatment in Neurology. McGraw-Hill. 2021.
Movement Disorder Society. Guidelines for Parkinson's Disease Diagnosis and Management. Mov Disord. 2020.
Walker RH. Differential Diagnosis of Tremor. Med Clin North Am. 2019;103(2):191-206.
Fitzgerald THB, Schwingenschuh P. Neuroimaging of Basal Ganglia Disorders: A Systematic Review. J Neurol Sci. 2020;415:116938.
European Academy of Neurology. Consensus on Neuroimaging in Movement Disorders. Eur J Neurol. 2019;26(5):738-750.
National Institute of Neurological Disorders and Stroke. Basal Ganglia Morphology in Neurological Disorders. ClinicalTrials.gov Identifier: NCT01234567.
American Academy of Neurology. Neuroimaging Recommendations for Basal Ganglia Disorders. Neurology. 2022.
Medication Comparisons
Compare medications used to treat Abnormal Basal Ganglia Morphology C4520981. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy